Jim Wilson secures $100M for global approach aimed at reviving gene therapy field

A gene ther­a­py pi­o­neer thinks he has a so­lu­tion to the field’s strug­gle to com­mer­cial­ize break­through cures: Go glob­al.

Jim Wil­son’s Philadel­phia-based com­pa­ny Gem­ma­Bio on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.